台康生技 6589 Balance Sheet
55.60+1.60 (+2.96%)11/13 Close · Vol. 2,213 lots
—
—
Line items
Auto Read
Latest
Latest2026 Q3
台康生技(6589)'s 2026 Q3 financial highlights: Total assets 11.21B · Debt ratio 30.7% · Equity 7.77B.
Total assets
11.21B
Debt ratio
30.7%
Equity
7.77B
About This Metric
Definition
Quarterly figures from the income statement, balance sheet and cash flow statement.
How to Read
Operating cash flow often reveals earnings quality better than reported net income.
Source
MOPS
Biotechnology and Medical Care
How much time do you spend wiring APIs, pulling data, and debugging — instead of thinking about strategy? Describe the signal, and Blave Agent researches and backtests it.
See what Blave Agent can do →